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Abstract
Background:  During vertebrate embryogenesis the initial stages of bone formation by
endochondral ossification involve the aggregation and proliferation of mesenchymal cells into
condensations. Continued growth of the condensations and differentiation of the mesenchymal
cells into chondrocytes results in the formation of cartilage templates, or anlagen, which prefigure
the shape of the future bones. The chondrocytes in the anlagen further differentiate by undergoing
a complex sequence of maturation and hypertrophy, and are eventually replaced by mineralized
bone. Regulation of the onset of chondrogenesis is incompletely understood, and would be
informed by comprehensive analyses of in vivo gene expression.
Results: Tibial and fibular pre-condensed mesenchyme was microdissected from mouse hind limbs
at 11.5 dpc, and the corresponding condensations at 12.5 dpc and cartilage anlagen at 13.5 dpc.
Total RNA was isolated, and cRNA generated by linear amplification was interrogated using mouse
whole genome microarrays. Differential expression was validated by quantitative PCR for Agc1,
Bmp8a, Col2a1, Fgfr4, Foxa3, Gdf5, Klf2, Klf4, Lepre1, Ncad, Sox11, and Trpv4. Further, independent
validation of the microarray data was achieved by in situ hybridization to analyse the expression of
Lepre1, Pcdh8, Sox11, and Trpv4 from 11.5 dpc to 13.5 dpc during mouse hind limb development.
We found significant differential expression of 931 genes during these early stages of
chondrogenesis. Of these, 380 genes were down-regulated and 551 up-regulated. Our studies
characterized the expression pattern of gene families previously associated with chondrogenesis,
such as adhesion molecules, secreted signalling molecules, transcription factors, and extracellular
matrix components. Gene ontology approaches identified 892 differentially expressed genes not
previously identified during the initiation of chondrogenesis. These included several Bmp, Gdf, Wnt,
Sox and Fox family members.
Conclusion:  These data represent the first global gene expression profiling analysis of
chondrogenic tissues during in vivo development. They identify genes for further study on their
functional roles in chondrogenesis, and provide a comprehensive and important resource for future
studies on cartilage development and disease.
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Background
Developing a detailed knowledge of the developmental
pathways involved in limb skeletogenesis is important for
understanding skeletal abnormalities and disease proc-
esses, and for further unravelling the fundamental regula-
tory pathways that control development. The
development of the vertebrate limb skeleton is initiated
when multipotent mesenchymal cells in the limb bud
aggregate to form mesenchymal condensations which
prefigure the skeletal elements. Cells within the pre-chon-
drogenic condensation up-regulate cell adhesion mecha-
nisms and begin to synthesize specific extracellular matrix
molecules, and the condensations expand through a com-
bination of proliferation and recruitment of surrounding
mesenchyme. The generation of these condensations cre-
ates an environment which is conducive to chondrogenic
differentiation [1,2]. As the cells differentiate into
chondrocytes, they synthesize a framework of cartilage
matrix, known as an anlage, in the approximate shape of
the future bone. Chondrocytes in the centre of the anlage
proceed through a series of discrete developmental stages
that include proliferation, maturation and hypertrophy
[1,3-7]. The hypertrophic cartilage is first calcified and
then, following vascular invasion, replaced by primary
bone that is subsequently remodelled to form secondary
bone. This process radiates outwards from the centre of
the anlage with the development of highly ordered
growth plates that separate the cartilaginous epiphyses
from the bony diaphysis. Later in development, secondary
centres of ossification develop within the epiphyses and,
with subsequent fusion of the ossification centres during
puberty, endochondral ossification and bone growth
ceases.
The regulatory network that controls early chondrogenesis
is incompletely understood although several key compo-
nents have been characterized. Prior to pre-chondrogenic
mesenchymal condensation in the developing vertebrate
limb bud, Bmp expression is upregulated in the mesen-
chyme flanking the anterior and posterior margins and in
the presumptive interdigital mesenchyme, in a manner
consistent with a role for these genes in limb patterning
and in initiating chondrogenesis and skeletal develop-
ment [8,9]. Furthermore, viral misexpression of the Bmp-
antagonist, Noggin, in the developing limb during embry-
ogenesis [10] and targeted over-expression of Noggin in
chondroprogenitor cells [11], both result in complete
blockage of mesenchymal condensation and chondrogen-
esis, proving the requirement for Bmp signalling in the
initiation of chondrogenesis. Bmp signalling serves multi-
ple purposes during the initiation of chondrogenesis; it
may contribute to the recruitment of cells to the conden-
sation, the proliferation of cells within the condensation,
as well as regulating the expression of genes involved in
driving the differentiation of condensed mesenchyme [2].
In addition to the roles of Bmps in skeletal development
per se, Bmp, along with Bmp antagonists (eg., chordin and
noggin) and members of the Gdf (growth and differentia-
tion factor) family are involved in controlling the cartilage
condensations that develop into the synovial joint. The
Fgf family of growth factors and their receptors also play
an important role in chondrocyte differentiation, possibly
by limiting chondrocyte proliferation, since activating
mutations in FGFR3 cause achondroplasia and thanato-
phoric dysplasia and Fgfr3-deficient mice have an
enlarged growth plate. A critical component of chondro-
cyte lineage specification is Sox9 (a high mobility group
transcription factor), which exerts its influence over chon-
drogenesis, in part, by regulating the expression of multi-
ple cartilage-specific proteins including Col2a1 [12]. The
influence of Sox9 on chondrogenesis is largely dependent
upon Sox5 and Sox6, with which it co-regulates the chon-
drogenic program [13].
In addition to the signalling cascades, the extracellular
matrix (ECM) plays a fundamental role in morphogenesis
and development by regulating cell differentiation, prolif-
eration, adhesion, and migration, and by modulating
growth factor bioavailability. Mesenchymal condensa-
tions are characterized by the expression of a specific
ECM, components of which include fibronectin [14],
tenascin C [15], NG2 proteoglycan [16], syndecan [17],
and chondroitin-sulphate proteoglycans [18]. The ECM
has important roles in promoting the condensation and
differentiation of mesenchymal cells [2]. As the cells dif-
ferentiate into chondrocytes they express specific ECM
components with unique functional and biological char-
acteristics which are critical for cartilage structure and
function [19,20]. The predominant, well-characterized
cartilage matrix components are the proteoglycan, aggre-
can, and members of the collagen protein family. Colla-
gen II is a major homotrimeric collagen expressed
throughout the cartilage that interacts specifically with
other minor collagens such as IX and XI to modulate inter-
fibrillar interactions between the heterotypic collagen
fibrils [21]. Mutations in many of these collagen genes
have been identified in human chondrodysplasias and in
mouse models [7,22,23]. Collagen VI is a microfibrillar
collagen which is found localized in the pericellular space
around chondrocytes in epiphyseal cartilage.
Cartilage contains many other proteins, some of which
have been well-characterized and whose roles in cartilage
structure and function have been elucidated [19,24-27].
Some of the best characterized components are the small
leucine-rich proteins (SLRPs), such as decorin, fibromod-
ulin, lumican and biglycan which interact with collagen
fibrils and influence collagen fibrillar architecture and
function. These SLRPs have growth factor binding proper-
ties that may have profound influences on cartilage cellBMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
Page 3 of 17
(page number not for citation purposes)
proliferation. Cartilage oligomeric matrix protein also
binds collagen fibrils and may also mediate cell-matrix
interactions. Other proteins include chondroadherin and
thrombospondin which have cell-matrix binding proper-
ties; tenascins, osteonectin and members of the matrilin
family, matrilins 1 and 3, that are thought to form inter-
acting assemblies integrating the collagen and proteogly-
can networks.
While a number of the chondrogenesis genes have been
extensively characterized, the full spectrum of components
involved in regulating chondrogenesis during limb devel-
opment has yet to be determined. However, with the
advent of high quality whole genome microarrays we now
have the unique opportunity to determine the comprehen-
sive gene expression pattern of processes such as chondro-
genesis, to define novel components and further unravel
the complex developmental processes involved. The appli-
cation of such expression profiling approaches to cartilage
formation in vivo has thus far been restricted by the techni-
cal challenge of obtaining high quality RNA from the tar-
get tissues. Consequently, expression studies to date have
been conducted on either whole mouse limbs [28,29] or
on in vitro models of chondrogenesis [30-32]. While these
studies have been useful in identifying some chondrogenic
genes, they suffer from the limitations of analysing hetero-
geneous tissues or the complex gene expression conse-
quences that may result from in vitro culture.
In this study we report the first global gene expression pro-
filing analysis of the transition of pre-condensed mesen-
chymal cells into mesenchymal condensations, and their
subsequent differentiation into chondrocytes, using tissue
microdissected from in vivo mouse limb buds. By compar-
ison of the gene expression profiles of cartilage pre-con-
densation tissue at 11.5 dpc, mesenchymal condensations
at 12.5 dpc, and differentiated cartilage tissue at 13.5 dpc,
we were able to identify the candidate gene cohorts
involved in the initiation of chondrogenesis and in the
early development of cartilage anlagen. As well as identi-
fying novel genes that may be critical in the regulation and
maintenance of chondrogenesis, our data allowed us to
present the first comprehensive expression analysis of the
known developmentally important gene families during
in vivo chondrogenesis during mouse limb skeletal devel-
opment. These data provide confirmation of the role of
many members of these key gene families, and also impli-
cate other members of these, and other gene families in
chondrogenesis for the first time.
Results and discussion
Microdissected samples from 11.5 dpc to 13.5 dpc 
encompass the initial developmental steps of 
chondrogenesis
Prior to microarray analysis, the differential expression of
selected key markers of mesenchymal condensation and
chondrogenesis was assayed by semi-quantitative PCR to
confirm the developmental stage represented by each
microdissected tissue sample (Fig. 1). The genes chosen
for semi-quantitative PCR analysis were N-cadherin
(Ncad), aggrecan (Agc1), collagen II (Col2a1), cartilage
oligomeric matrix protein (Comp), cartilage link protein
(Hapln1, hyaluronan and proteoglycan link protein 1)
and the gene encoding S12 ribosomal RNA, which was
included as a loading standard. Ncad is a cell-cell adhe-
sion molecule whose role in mesenchymal condensation
during limb development has been well characterized
[33]. Expression of aggrecan, collagen II, Comp and carti-
lage link protein is indicative of cartilage formation [34].
Semi-quantitative PCR demonstrated Ncad  transcripts
were abundant at 11.5 dpc, immediately prior to the com-
mencement of mesenchymal condensation. A marked
decrease in Ncad transcription was observed by 12.5 dpc
and this low level of expression was maintained until 13.5
dpc. Agc1 and Col2a1 were present at low levels in 11.5
dpc embryos, well before the deposition of significant
extracellular matrix. Transcription of both these markers
increased by 12.5 dpc, and they became highly abundant
by 13.5 dpc. Neither Comp nor Hapln1 transcripts were
present at levels detectable by semi-quantitative RT-PCR
Semi-quantitative PCR analysis of cartilage specific gene  expression in microdissected limb cartilage condensations Figure 1
Semi-quantitative PCR analysis of cartilage specific 
gene expression in microdissected limb cartilage 
condensations. Agarose gel electrophoresis of PCR prod-
ucts generated by primers specific for N-cadherin (Ncad), 
aggrecan (Agc1), procollagen II alpha I (Col2a1), cartilage link 
protein (Hapln1; hyaluronan and proteoglycan link protein 1), 
and ribosomal protein S12 (S12).BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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at 11.5 dpc. Low-level transcription of Comp and Hapln1
was observed at 12.5 dpc, and increased dramatically by
13.5 dpc. These data provided clear evidence that the
microdissected regions of the limb buds represented mes-
enchymal condensations undergoing the in vivo transition
from undifferentiated chondroprogenitor cells to differ-
entiated chondrocytes.
Whole genome expression profiling
As an overall representation of the microarray hybridiza-
tions, M/A scatter plots were generated for each time point
comparison in which the mean signal intensity (Average
Log2 Intensity; A) for each microarray probe was plotted
against the relative fold difference for that probe (Fig. 2).
Negative control probes, which are not complementary to
any mouse mRNA sequences, have been included on
these microarrays by the manufacturer to gauge non-spe-
cific, background fluorescence. Using these probes, it was
determined that an average Log2 intensity of less than or
equal to six represented background fluorescence (indi-
cated by dashed orange line in Fig. 2).
Scatter plot comparisons were generated by subtracting
the signal intensity of 11.5 dpc from 12.5 dpc (Fig. 2A),
12.5 dpc from 13.5 dpc (Fig. 2B), and 11.5 dpc from 13.5
dpc (Fig. 2C). By plotting the data in this manner for each
of the three comparisons, genes which were expressed in
equal relative abundance between time points were plot-
ted close to zero on the relative fold difference (vertical;
M) axis. Genes which were more highly expressed at the
later time points were plotted on the positive scale of the
relative fold difference axis (red). Conversely, genes which
were more highly expressed at the earlier time points were
plotted on the negative scale of the relative fold difference
axis (green). The data-points for selected markers of mes-
enchymal condensation (Ncad, growth differentiation fac-
tor 5 – Gdf5, and protocadherin 8 – Pcdh8),
chondrogenesis (Agc1,  Col2a1,  Comp  and matrilin 1 –
Matn1), myogenesis (myogenic differentiation 1 –
Myod1), and chondrocyte hypertrophy (procollagen type
10 alpha 1 – Col10a1), as well as a house keeping gene as
an internal standard (hydroxymethylbilane synthase –
Hmbs) have been highlighted in each scatter plot. It can be
seen in each of the plots in Figure 2 that the selected mark-
ers of chondrogenesis were found to be expressed more
highly in the later time point, while markers of mesenchy-
mal condensation were found to be expressed more
highly at the earlier time point. Consistently, the average
Log2 intensity for Col10a1 was found to be below six, con-
firming that Col10a1, a marker of cartilage hypertrophy,
was not expressed in any of the microdissected tissues and
that the cartilage anlagen microdissected at 13.5 dpc were
pre-hypertrophic. For Myod1, the average Log2 intensity
was found to be very close to background level and the rel-
ative fold difference close to zero, indicating negligible
Myod1  expression in these tissues, and suggesting that
there was no significant contamination of the microdis-
sected tissues by myogenic precursors.
In order to generate global representations of biological
processes driving chondrogenesis, the microarray data
were mined using OntoExpress gene ontology software.
Genes up-regulated or down-regulated between 11.5 dpc
to 13.5 dpc by at least three-fold, and for which an average
Log2 intensity >6 was detected, were classified according
to biological process (see Additional file 1). By this
method, 931 significantly differentially expressed genes
were identified – 380 down-regulated genes and 551 up-
regulated genes. These genes are shown in Additional file
2. The full microarray dataset are available from the Gene
Expression Omnibus (GEO) database repository http://
www.ncbi.nlm.nih.gov/geo.
Validation of microarray data
Three approaches were taken to validate the microarray
dataset generated in the present study – quantitative PCR
(qPCR), in situ hybridization, and an extensive compari-
son of the gene expression dataset generated in this study
with expression and function data pertaining to the same
genes in the scientific literature. To provide microarray
validation over a wide range of gene expression levels we
performed qPCR on genes expressed at high levels by
chondrocytes, such as extracellular matrix components
(eg. Col2a1), and also those expressed at much lower lev-
els, such as transcription factors (eg. Foxa3). In addition,
array validation was performed for representative genes
from the developmentally important gene families; adhe-
sion molecules, secreted signalling molecules, transcrip-
tion factors and extracellular matrix molecules.
Quantitative PCR
Using unmodified cRNA samples amplified in parallel to
those cRNA samples generated for the microarray analy-
ses, qPCR was performed on selected genes as a technical
validation for the microarray data. qPCR was performed
on Agc1 (Fig. 3A), Bmp8a (Fig. 3B), Col2a1 (Fig. 3C), Fgfr4
(Fig. 3D), Foxa3 (Fig. 3E), Gdf5 (Fig. 3F), Klf2 (Fig. 3G),
Klf4 (Fig. 3H), Lepre1 (Fig. 3I), Ncad (Fig. 3J), Sox11 (Fig.
3K), and Trpv4 (Fig. 3L). For each marker, a close correla-
tion was observed between the pattern of differential gene
expression determined using either technique, with high-
est expression for markers of mesenchymal condensation
seen between 11.5 dpc and 12.5 dpc, and highest expres-
sion for markers of chondrogenesis seen at 13.5 dpc.
In situ hybridization
In order to validate the microarray data further with inde-
pendent, biological replicates, in situ hybridization was
performed on sagittal sections from 11.5 dpc, 12.5 dpc,
and 13.5 dpc mouse hind limb buds using probes forBMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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Mouse whole genome microarray M/A scatter plots Figure 2
Mouse whole genome microarray M/A scatter plots. A) 12.5 dpc – 11.5 dpc. B) 13.5 dpc – 12.5 dpc. C) 13.5 dpc – 11.5 
dpc. M represents the log ratio of the two dyes and A represents the average Log2 intensity. Yellow spots with blue outline 
indicate the expression data for selected genes. The dashed blue line indicates a fold difference of zero representing no differ-
ential expression between the two samples analysed. The dashed orange line indicates a average Log2 intensity (A) of 6, repre-
senting the background signal intensity.BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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Sox11 (Fig. 4A–C), Pcdh8 (Fig. 4D–F), Lepre1 (Fig. 4G–I),
and Trpv4 (Fig. 4J–L). In each case, the gene expression
detected by in situ hybridization corroborated the expres-
sion profiles generated by microarray and clarified the
expression of these genes in the limb bud beyond the
microdissected areas.
Strong expression of Sox11 was observed throughout the
limb bud and also in the adjacent somites at 11.5 dpc (Fig.
4A). At 12.5 dpc, expression of Sox11  was generally
weaker than at 11.5 dpc, and found to be most highly
expressed in the interdigital mesenchyme distally, and
localized to the tibial and fibular mesenchymal condensa-
Comparison of differential expression profiles of selected genes analysed by quantitative real time PCR or microarrays Figure 3
Comparison of differential expression profiles of selected genes analysed by quantitative real time PCR or 
microarrays. Expression was analyzed in amplified mRNA by quantitative real time PCR analysis (qPCR; yellow bars) or 
microarray analysis (blue bars) for A) aggrecan (Agc1); B), Bmp8a; C), Col2a1; D), Fgfr4; E), Foxa3, F), Gdf5; G), Klf2, H), Klf4; I), 
Lepre1; J), Ncad; K), Sox11; L) Trpv4. qPCR experiments were performed in triplicate.BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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tions, as well as the anterior and posterior margins of the
limb bud proximally (Fig. 4B). At 13.5 dpc, Sox11 expres-
sion was very weak distally and absent from the tibia and
fibula (Fig. 4C). This pattern of Sox11 expression agrees
with the expression profiles generated by microarray and
qPCR, where Sox11 was found to be down-regulated dur-
ing development of the tibial and fibular cartilage anla-
gen. Similarly, Pcdh8 also exhibited declining expression
levels from 11.5 dpc–13.5 dpc. At 11.5 dpc, Pcdh8 expres-
sion was detected in the precondensed tibial and fibular
In situ hybridization analysis of Sox11, Pcdh8, Lepre1 and Trpv4 in embryonic mouse hindlimbs Figure 4
In situ hybridization analysis of Sox11, Pcdh8, Lepre1 and Trpv4 in embryonic mouse hindlimbs. Antisense 
probes were used to determine the level and distribution of mRNA for each gene. Expression of Sox11 is widespread through-
out the limb bud and somites (arrowhead) at E11.5 but declines in level by E12.5 and becomes undetectable by E13.5. Pcdh8 is 
expressed within the pre-condensations of the tibia and fibula (arrowheads) at E11.5 but is downregulated by the condensation 
phase at E12.5. At this stage expression is detected in the tissue surrounding the femoral condensation (arrowhead) but 
declines to background levels by E13.5. Leprecan1 is not detectable at E11.5 but becomes visible in the femoral condensation at 
E12.5 (arrowhead) and is upregulated within the tibia and fibula at E13.5 (arrowheads). Trpv4 is not detectable within the limb 
buds at E11.5 or E12.5 but is strongly upregulated in the tibia and fibula at E13.5 (arrowheads). Distal is to the left in all images.BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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mesenchyme (Fig. 4D) but was absent from the distal
limb at E12.5 (Fig 4E). In contrast, Pcdh8 expression at
E12.5 was predominantly detected surrounding the femo-
ral condensation (Fig 4E) but became undetectable within
the limb by E13.5 (Fig 4F). Thus, as with the expression
profile generated by microarray for Pcdh8, in situ hybridi-
zation confirmed that expression of Pcdh8 is down-regu-
lated in the areas of tibial and fibular development.
Lepre1 expression was not detectable in the limb bud at
11.5 dpc (Fig. 4G). By 12.5 dpc, weak expression of Lepre1
was observed in the femoral, tibial, and fibular prechon-
drogenic mesenchymal condensations (Fig. 4H). Lepre1
was found to be highly expressed throughout the cartilage
anlagen, though not in the perichondrium, at 13.5 dpc
(Fig 4I). Similar results were obtained for Trpv4, which
was not detectable at either 11.5 dpc (Fig. 4J) or 12.5 dpc
(Fig. 4K), but which was highly expressed throughout the
cartilage anlagen at 13.5 dpc (Fig. 4L).
The in situ hybridization data presented here for Sox11,
Pcdh8, Lepre1, and Trpv4 are consistent with the expres-
sion profiles generated for these genes in the present study
by microarray analysis and qPCR. In so doing, they rein-
force the utility of the present microarray dataset for pro-
viding accurate information about the expression profiles
of developing chondrogenic tissues in vivo.
Comparative literature analysis
As a third approach to validating the microarray data gen-
erated in the present study, an extensive survey of the sci-
entific literature was carried out in order to compare our
gene expression dataset with expression and function data
pertaining to the same genes examined in previous studies
(see Additional file 3). For the 50 genes surveyed, we
found that our expression profiles were highly consistent
with previously published data, emphasising the value of
the present dataset as a tool for further understanding the
dynamic gene expression environment controlling in vivo
chondrogenesis.
Differential expression of gene families during 
chondrogenesis
Adhesion Molecules
Consistent with their roles in mediating cell-cell contacts,
it was found that most protocadherins (Fig. 5A) and cad-
herins (Fig. 5B) were down-regulated from 11.5 dpc –
immediately prior to the commencement of mesenchy-
mal condensation, to 13.5 dpc – when cartilage anlagen
have formed. The protocadherins are a family of type I
membrane proteins belonging to the cadherin super-
family which are characterized by multiple extracellular
cadherin domains and unique intracellular domains
bridged by a single membrane-spanning segment [35].
The function of the protocadherins is unclear and while
they may function in cell-cell adhesion, they are also
likely to have a role in intercellular signalling. Of the dif-
ferentially regulated protocadherin (Pcdh) genes (Fig. 5A),
the most highly down-regulated were Pcdh8 and Pcdh10.
Pcdh9  and  Pcdh18  were also found to be significantly
down-regulated, but more highly expressed than Pcdh8
and Pcdh10. None of the protocadherins were found to be
significantly up-regulated during in vivo chondrogenesis.
To date, none of the protocadherins have been implicated
in chondrogenesis, and Pcdh8 is the only protocadherin
previously found to be expressed during limb develop-
ment [36].
The cadherin genes encode membrane-spanning proteins
characterized by multiple cadherin domains which medi-
ate calcium-dependent homophilic adhesion between
neighbouring cells in a wide range of developmental proc-
esses [37]. Among the cadherin (Cdh) genes (Fig. 5B),
Cdh8 and Cdh4 were found to exhibit the highest differen-
tial expression. Notably, expression of both of these genes
peaked during mesenchymal condensation at 12.5 dpc,
before being down-regulated in the cartilage anlagen at
13.5 dpc. Cdh11, although not significantly differentially
expressed, was found to be very highly expressed through-
out  in vivo chondrogenesis.  Cdh11  has recently been
shown to be a discriminative factor between articular and
growth plate cartilage chondrocytes [38]. N-cadherin
(Ncad, Cdh2) was found to be very highly expressed and
was down-regulated by almost 3-fold from 11.5 dpc to
13.5 dpc, consistent with its characterized role in conden-
sation.
Ncam was highly expressed throughout in vivo chondro-
genesis, and marginally up-regulated between 11.5 dpc
and 13.5 dpc. It is recognized that in the context of chon-
drogenesis, cell-cell adhesion is most likely mediated pri-
marily by Cdh2 [33] and Cdh11 – in conjunction with
other factors such as Ncam1 [39]. This view is supported
by the findings presented here, in which Ncam1, along
with Cdh2 and Cdh11 were highly expressed during the
initiation of chondrogenesis, while other cadherins were
expressed at a much lower level (Fig. 5B).
Secreted signalling molecules
The relative differential expression of genes belonging to
major families of signalling molecules secreted during in
vivo chondrogenesis are shown (Fig. 5C–F). Included in
this category are the bone morphogenetic protein (Bmp)
family (Fig. 5C), the growth differentiation factor (Gdf)
family (Fig. 5D), the wingless-related MMTV integration
site (Wnt) family (Fig. 5E), and the fibroblast growth fac-
tor family (Fig. 5F). The chondroinductive potential of the
Bmp family has been extensively analysed, and it is
known that chondrogenesis may be induced by the activ-
ity of Bmp2 [40], Bmp4 [41], Bmp5 [42], Bmp6 [43], andBMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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Microarray differential expression profiles of selected developmental gene families Figure 5
Microarray differential expression profiles of selected developmental gene families. A), protocadherins (Pcdh); B), 
cadherins (Cdh); C), bone morphogenetic proteins and bone morphogenetic protein receptors (Bmp and Bmpr); D), growth 
differentiation factors (Gdf); E), Wnt family, (Wnt); F), fibroblast growth factors and fibroblast growth factor receptors (Fgf and 
Fgfr); G), homeobox transcription factors (Hox); H), T-box transcription factors (Tbx); I), Sry-like homeobox transcription fac-
tors (Sox); J), forkhead/winged helix box transcription factors (Fox); K), selected non-collagenous extracellular matrix mole-
cules. Yellow bars indicate relative expression at 11.5 dpc. Blue bars indicate relative expression at 12.5 dpc. Orange bars 
indicate relative expression at 13.5 dpc. For each gene, the time point at which the relative expression was lowest was defined 
as one, and this was used to calculate the relative expression at the remaining time points. Numbers above each gene denote 
average Log2 intensity (A) for that gene.BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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Bmp7 [44]. Moreover, expression of Bmp8a in developing
long bones has been demonstrated, and it is known to
map to the mouse achondroplasia locus [45], suggesting
that it too may be an important regulator of chondrogen-
esis. Consistent with these observations, Bmp8a  was
found to be the most highly differentially expressed Bmp
gene, up-regulated over 50-fold between 11.5 dpc and
13.5 dpc. Bmp6 and Bmp7 were also highly differentially
expressed. Bmp7 was more highly expressed than Bmp8a,
while overall expression of Bmp6 was low. Although not
highly differentially expressed, Bmp1  was found, like
Bmp7, to be very highly expressed. Expression of Bmp2 was
found to be absent from this assay of in vivo chondrogen-
esis.
It is known that the Gdf family contributes to the regula-
tion of chondrogenesis. Gdf5 may induce chondrogenesis
in vitro [46], and it has been used to induce ectopic chon-
drogenesis in vivo, in part by stimulating expression of
another marker of chondrogenesis, transcription factor
Barx2 [47]. Moreover, single gene knock-outs of Gdf5 and
Gdf6  resulted in defects in multiple elements of the
appendicular and craniofacial skeletons, while a more
severe skeletal phenotype was observed for the Gdf5/Gdf6
double knock-out mouse [48]. These findings are consist-
ent with the extremely similar differential expression pro-
files determined for Gdf5 and Gdf6 in the present study, in
which the expression of both genes peaked significantly at
12.5 dpc (Fig. 5D). By contrast, little is known of the role
of Gdf10 in chondrogenesis. Indeed, the only report to
date in which Gdf10 has been implicated in skeletal biol-
ogy concerned its expression during bone repair in a
model of fracture healing [49]. The steady up-regulation
of Gdf10 observed between 11.5 dpc and 13.5 dpc in the
present study however, suggests that Gdf10 may play an
important role in mesenchymal condensation and
chondrocyte maturation. Overall, six Gdf  genes were
expressed during in vivo chondrogenesis (Fig. 5D). Gdf6
was found to be most highly differentially expressed,
peaking at 12.5 dpc, although overall expression of Gdf6
was very low. Both Gdf5  and  Gdf10  were strongly
expressed, and highly differentially expressed. Gdf1,
although not highly differentially expressed, was found to
be expressed strongly throughout in vivo chondrogenesis.
It is well established that Wnt proteins mediate important
signalling pathways at various stages of chondrogenesis.
Accordingly, Wnt gene expression in vivo is found to be
spatially and temporally restricted within the developing
cartilage anlage. Wnt4 expression is localized to the devel-
oping joints, Wnt5a to the perichondrium, and Wnt5b to
the perichondrium and prehypertrophic chondrocytes
[50,51]. Moreover, functional work presented in the same
studies demonstrated that Wnt4 promotes chondrocyte
hypertrophy, while Wnt5a and Wnt5b operate conversely,
by impeding terminal chondrocyte differentiation. Thus,
while the data generated by microarray analysis here pro-
vides valuable information about relative expression lev-
els, the authors recognise that it cannot provide
information regarding the spatial distribution of tran-
scripts within the microdissected tissues. Among the Wnt
family, only Wnt11 and Wnt5b were strongly expressed,
and only one Wnt (Wnt4) was found to be highly differ-
entially expressed and dramatically up-regulated between
12.5 dpc and 13.5 dpc (Fig. 5E). Conversely, frizzled-
related protein (Frzb), a Wnt antagonist, was found to be
strongly expressed, and down-regulated between 11.5 dpc
and 13.5 dpc (see Additional file 2).
Despite their prominent role in controlling aspects of
endochondral bone growth, little is known about the
expression or function of Fgf ligands and Fgf receptors
within mesenchymal condensations and subsequent car-
tilage anlagen [52]. Recent work however points to a role
for Fgf18 in regulating chondrocyte proliferation and
hypertrophy during the earliest stages of chondrogenesis
(expression being detected as early as 14.5 dpc) through
interaction with Fgfr3 [53]. Our differential expression
data (Fig. 5F) support and extend these findings by reveal-
ing significant up-regulation of both Fgf18  and  Fgfr3
between 11.5 dpc and 13.5 dpc, and by clarifying the dif-
ferential expression patterns of Fgf ligands and Fgf recep-
tors within chondrogenic tissue in vivo. Of considerable
interest was the finding that Fgfr4 expression is signifi-
cantly up-regulated between 11.5 dpc and 13.5 dpc. Fgfr4
has not previously been associated with chondrogenesis,
although it is known to mediate early events in the signal-
ling cascade regulating skeletal muscle development in
the developing limb [54]. The Fgfr4 differential expression
data presented here imply that in addition to the role of
Fgf4 in myogenesis, it may also have a role in chondro-
genesis.
Transcription factors
The first families of transcription factors considered here
are the homeo box (Hox) genes (Fig. 5G). A large group of
genes comprised of four gene clusters, the Hox genes were
mostly found to be down-regulated from 11.5 dpc to 13.5
dpc, although the opposite trend was observed for some
Hox  genes. Only three members (Hoxa7,  Hoxa10, and
Hoxa11) of the Hoxa gene cluster were strongly expressed.
The most highly differentially expressed of these was
Hoxa10. Hoxa7 and Hoxa11 were more strongly expressed
than Hoxa10 however, although neither was significantly
differentially expressed. Four Hoxb  genes were weakly
expressed during in vivo chondrogenesis, and none of
them were highly differentially expressed. Only one Hoxc
gene (Hoxc10) was highly differentially expressed during
in vivo chondrogenesis, down-regulated by almost 3-fold
from 11.5 dpc to 13.5 dpc. None of the other Hoxc genesBMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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were significantly differentially expressed, although the
expression level of Hoxc9  was found to be very high
throughout the time course. Most of the Hoxd gene cluster
were very weakly expressed. The most highly down-regu-
lated Hoxd genes were generally the more 3' members of
the cluster (Hoxd9, Hoxd10, Hoxd11, and Hoxd13). While
Hox genes have established roles in pattern formation,
they may play additional roles in chondrogenesis. The
overall down-regulation of the more highly expressed
members of the Hox family suggests that Hox gene silenc-
ing may be required for the progression of cartilage forma-
tion. Transgenic mouse data showing that the persistent
expression of Hoxa2  in cells entering chondrogenesis
impairs cartilage development and causes chondrodyspla-
sia [55], supports this inhibitory role for at least a subset
of Hox genes. A further early role for Hox genes in regulat-
ing the expression of the key chondrogenic transcription
factor, Sox9, has been shown in recent experiments [56].
Interestingly, while many Hox  genes were found to be
down-regulated in chondrogenic tissue from 11.5 dpc to
13.5 dpc in the present study, three Hox genes (Hoxa7,
Hoxb5, and Hoxc5) were up-regulated during this time by
close to or greater than two-fold. This is the first time that
vertebrate limb expression data has been published for
Hoxa7, Hoxb5, and Hoxc5.
Eight T-box (Tbx) genes were expressed during in vivo
chondrogenesis (Fig. 5H). Of these Tbx15,  Tbx3  and
Tbx18, were all strongly expressed and highly down-regu-
lated from 11.5 dpc to 13.5 dpc.
Expression of 16 Sry-box (Sox) genes was detected during
in vivo chondrogenesis (Fig. 5I). Of these, four were found
to be highly expressed although none of these four genes
were significantly differentially expressed. Among these
genes were Sox9  and  Sox6. Moderate expression levels
were detected for five Sox genes and of these, only Sox8
was significantly differentially expressed, up-regulated by
almost 4-fold between 11.5 dpc and 13.5 dpc. Seven Sox
genes were found to be expressed weakly during in vivo
chondrogenesis. Expression data generated in the present
study are consistent with the importance of Sox9 through-
out chondrogenesis [57,58]. Sox9 was not highly differen-
tially expressed from 11.5 dpc to 13.5 dpc but its average
Log2 intensity was found to be extremely high, indicating
ubiquitously high expression of Sox9 throughout the tran-
sition from pre-chondrogenic mesenchymal cell to fully
differentiated chondrocyte. It is known that Sox9 exerts its
influence over chondrogenesis, in part, by regulating the
expression of multiple prominent components of the car-
tilage matrix including the quintessential chondrocyte
marker,  Col2a1  [12]. This transcriptional activity was
found to be largely dependent upon the combined activity
of a long form of Sox5 (L-Sox5), and Sox6 [59]. In the
present study, Sox6 expression closely resembles that of
Sox9 in that although it was not found to be highly differ-
entially expressed throughout chondrogenesis, its abso-
lute expression level (average Log2 intensity) was found to
be very high.
Interestingly Sox5 expression was quite low in the present
study (Fig. 5I). It is possible that this result does not accu-
rately reflect the abundance of Sox5 transcripts because of
technical limitations with array design. The single probe
for Sox5 on the microarray is located 1445 bp upstream of
the 3'-end of the mouse Sox5 coding sequence, and since
the amplified RNA used to interrogate to array has an
inherent 3' bias, it is likely that this results in an inability
to hybridize efficiently.
Our results also demonstrate that additional Sox genes,
Sox4, Sox8, Sox10, Sox11 and Sox13 participate in chon-
drogenesis  in vivo. Previous studies have shown Sox4
expression localized to diaphyseal hypertrophic chondro-
cytes during the commencement of long bone ossifica-
tion, and later in the hypertrophic chondrocytes of the
embryonic growth plate [60], as well as along the poste-
rior margin, and proximally on the anterior margin of
chicken limb buds at a stage equivalent to mouse hind-
limb 11.5 dpc [61]. Expression of Sox8 and Sox10 has also
been noted previously in limb development, occurring,
like that of Sox5, Sox6, and Sox9, in a manner which essen-
tially prefigures the developing skeleton [62]. Moreover,
in the same study it was noted that each of these genes was
up-regulated in ectopic cartilages in response to Bmp7,
implying roles for Sox8 and Sox10 in chondrogenesis. The
highly similar expression patterns detected for Sox8 and
Sox10 here suggest that these genes may have overlapping
functions in vivo. That Sox8 and Sox10 are most highly
expressed at 13.5 dpc points towards roles for these genes
in vivo in chondrocyte maturation, or in preparing
chondrocytes for subsequent hypertrophy. Sox13 was up-
regulated from 11.5 dpc to 12.5 dpc, to a level at which it
was maintained until 13.5 dpc. The association of Sox13
with limb bud development has recently been demon-
strated by immunohistochemistry [63].
Another large transcription factor family of which multi-
ple members were found to exhibit dynamic patterns of
differential expression was the forkhead box (Fox) gene
family (Fig. 5J). Three Fox  genes were very highly
expressed. Notably, Foxc2 was significantly up-regulated,
almost 3-fold between 11.5 dpc and 12.5 dpc, and
approximately 3.5 fold by 13.5 dpc. Furthermore, Foxo1
and Foxp1 were both strongly expressed, and differentially
expressed during in vivo chondrogenesis, although the
expression patterns of these transcription factors differed
markedly. Whereas Foxo1  expression was found to
increase in a linear fashion by almost 5-fold between 11.5BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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dpc and 13.5 dpc, Foxp1 expression peaked at 12.5 dpc,
before dropping by greater than 3-fold by 13.5 dpc. A fur-
ther four Fox genes were moderately expressed. One of
these genes, Foxa3, was dramatically up-regulated
between 11.5 dpc and 13.5 dpc, by over 20-fold. Seven
other Fox genes were weakly expressed and of these, only
Foxd1  was differentially expressed, up-regulated more
than 4-fold from 11.5 dpc to 13.5 dpc.
Only two Fox genes however, have been implicated in
skeletogenesis to date. Foxa3  transcripts have been
detected by in situ hybridization in the vertebrae and ribs
of 14.5 dpc mouse embryos [64], while expression of
Foxc2 has been observed during axial and appendicular
skeletogenesis in mouse. Interestingly, in the developing
limb, it was found that Foxc2 transcripts localized to the
periphery of the mesenchymal condensation at 12.5 dpc,
and the perichondrium of the cartilage anlagen at 13.5
dpc [65]. The function of Foxa3 and Foxc2 during chon-
drogenesis remains unknown.
Extracellular matrix molecules
Chondrogenesis involves the secretion of a complex extra-
cellular matrix rich in collagens and non-collagenous pro-
teoglycans. Thus, it was expected that many genes
encoding components of cartilage extracellular matrix
would be dramatically up-regulated during in vivo chon-
drogenesis. The results which follow include the differen-
tial expression patterns observed for prominent non-
collagenous extracellular matrix proteins as well as for the
collagen gene family and the integrin family, which
encode extracellular matrix receptors.
As predicted, many genes encoding cartilage extracellular
matrix molecules were highly up-regulated (Fig. 5K). It
was found that cartilage link protein (Hapln1, hyaluronan
and proteoglycan link protein 1) was highly expressed,
and by far the most highly up-regulated gene during in
vivo  chondrogenesis, its expression having increased
approximately 200-fold between 11.5 dpc and 13.5 dpc.
Cartilage oligomeric matrix protein (Comp), aggrecan
(Agc1), matrilin 1 (Matn1), and chondroitin sulphate pro-
teoglycan 4 (Cspg4) were also highly expressed and very
highly up-regulated between 11.5 dpc and 13.5 dpc. Mat-
rilin 3 (Matn3) and matrilin 2 (Matn2) were also very
highly up-regulated, although they were expressed only
moderately. The most highly expressed of these genes
were Cspg4 and Matn4, although Matn4 was not found to
be differentially expressed. Fibronectin 1 (Fn1) was not
differentially expressed, and its expression was moderate.
Versican (Vcan) expression was down-regulated by over
10-fold from 11.5 dpc to 13.5 dpc while Tenascin C (TnC)
expression was moderate but was up-regulated by almost
8-fold. As with other components of the cartilage ECM,
many collagen genes and integrins were differentially
expressed during in vivo chondrogenesis (see Additional
file 4).
Ontology approaches identify a large cohort of novel 
genes expressed during chondrogenesis for further 
investigation
The importance of this study is realised by the utility of
the microarray data as an invaluable resource for investi-
gating the roles of novel genes during in vivo chondrogen-
esis. In order to identify such genes, ontological
approaches were undertaken to classify differentially
expressed genes according to biological process and thus
identify those for which an association with ontologies
relating to cartilage and skeletal development has yet to be
made. Accordingly, the 931 genes for which a differential
expression of greater than three and a average Log2 inten-
sity of greater than or equal to six was observed between
11.5 dpc – 13.5 dpc (see Additional file 2) were interro-
gated by GOstat software using the MGI GO gene associa-
tion database http://gostat.wehi.edu.au/ in order to
identify highly represented gene ontologies. As predicted,
ontologies relating to cartilage and skeletal development
were observed. Among the down-regulated genes, 9 were
classified under 'skeletal development' (GO:0001501).
Among the up-regulated genes, 30 were classified under
'skeletal development' (GO:0001501), 20 under 'ossifica-
tion' (GO:0001503), 15 under 'cartilage development'
(GO:0051216), 5 under 'chondrocyte differentiation'
(GO:0002062), and 4 under 'cartilage condensation'
(GO:0001502). Of these genes, 44 appeared under multi-
ple classifications. Therefore, a total of 39 genes were clas-
sified by GOstat analysis as having previously been
implicated in cartilage or skeletal development, leaving
892 novel genes for which an ontological association with
chondrogenesis has yet to made. Thus, this study has
served to identify a large cohort of novel genes whose
expression or function during in vivo chondrogenesis is
uncharacterized and potentially represents important
developmental regulators. This dataset is therefore an
important reference for future gene discovery and stands
as an invaluable resource for ongoing research into skele-
tal development and disease.
Our studies are the first comprehensive attempt to iden-
tify genes which regulate the initiation of chondrogenesis
in vivo. We have described the differential expression pat-
terns observed for major gene families encoding adhesion
molecules, transcription factors, and signalling molecules
known to be important in many developmental proc-
esses, and have implicated members of these develop-
mental gene families in chondrogenesis for the first time.
In addition, we have identified many new candidate genes
that may be involved in the initiation of chondrogenesis,
on the basis of their differential expression patterns
observed here, in combination with their known associa-BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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tion with specific biological processes or known molecu-
lar function.
Conclusion
By conducting whole genome microarray analyses of RNA
derived specifically from tissues representative of key
stages of in vivo limb bud chondrogenesis, we have gener-
ated and thoroughly validated expression profiles which
for the first time define the suite of genes expressed by
chondrogenic tissues in the formation of cartilage from
pre-condensed mesenchyme during embryogenesis. In
doing so, we have defined the expression profiles of
known chondrogenically and developmentally important
gene families expressed by chondrogenic tissues during
cartilage formation, and have identified 931 genes signif-
icantly differentially expressed during this process, con-
sisting of large gene cohorts particular to each stage of
cartilage development – pre-condensed mesenchyme,
mesenchymal condensations, and cartilage anlagen. It is
anticipated that these data will be important in further
unravelling the fundamental control networks which
drive cartilage development, in investigating the molecu-
lar pathology of inherited skeletal diseases, and in explor-
ing which properties of pre-skeletal limb bud
mesenchymal cells predispose them to efficient chondro-
genic differentiation, the understanding of which prom-
ises to aid research into therapeutic cartilage repair. Thus,
the data-set generated in this study stands as an important
development for skeletal biology research.
Methods
Microdissection of chondrogenic condensations and 
preparation of RNA
We have previously reported global differential expression
profiles corresponding to zones of the growth plate gener-
ated by microarray analysis of RNA derived from tissue
microdissected from long bones of Swiss white mice [66].
So that these datasets could be compared with those of the
present study, Swiss white mice were used here also.
Accordingly, pregnant female Swiss white mice were sacri-
ficed in accordance with Institutional Animal Ethics
guidelines and embryos were harvested at 11.5 dpc, 12.5
dpc and 13.5 dpc and transferred to PBS at 4°C. The hind
limb buds were promptly dissected and embedded in Tis-
sue-Tek OCT (Sakura Fine Technical), snap-frozen in iso-
pentane and stored at -80°C. 6 μm sections of limb tissue
corresponding to the regions of tibial and fibular develop-
ment were prepared using a cryostat (Leica CM1850),
mounted on RNAse-free SuperFrost Plus slides (Biolab
Scientific), fixed in 70% ethanol, washed in RNAse-free
water, and dehydrated in 70%, 95%, and 100% ethanol
for thirty seconds each, and air-dried. Regions corre-
sponding to the mesenchymal condensations of develop-
ing tibiae and fibulae were microdissected from slides
immobilized on the stage of an inverted light microscope
(Leica DM IL) using an ophthalmic scalpel (Feather) fixed
to the scanning xy-object guide. Mesenchymal condensa-
tions and cartilage anlagen at 12.5 dpc and 13.5 dpc were
readily visible in untreated (ie fixed and dehydrated, but
not stained) sections by light microscopy, allowing pre-
cise microdissection of these tissues. In 12.5 dpc hind
limb sections, a prominent blood vessel was found to run
between, and perpendicular to the developing tibia and
fibula, thus appearing in the transverse plane as the tibia
and fibula came into view (Fig. 6). The appearance of this
blood vessel was used as a guide for locating the pre-
condensed mesenchymal cells in 11.5 dpc hind limb sec-
tions. 231 sections from a total of four 11.5 dpc mouse
hind limbs, three 12.5 dpc mouse hind limbs, and four
13.5 dpc mouse hind limbs were microdissected (Fig. 6).
The tissue from each time point was pooled into RNase-
free Eppendorf tubes and total RNA was extracted using
the RNeasy Micro Kit (Qiagen). To assess RNA yield,
purity, and integrity, total RNA samples were interrogated
by capillary electrophoresis with a Bioanalyzer 2100 (Agi-
lent Technologies), using a Series II RNA 6000 Pico Kit,
according to the manufacturer's specifications (Agilent
Technologies). All total RNA samples were confirmed to
be of high quality, with a RIN of >7.7 (Agilent). Total RNA
from tibial and fibular tissue microdissected from each
time point was linearly amplified [67] in two rounds
using the MessageAmp aRNA kit (Ambion) following the
manufacturer's instructions. 100–150 ng of first-round
amplified cRNA was used as template for each of the sec-
ond round amplifications. Quality and yield was assessed
by capillary electrophoresis. Amplified RNA samples
(1.25 μg) were fluorescently labelled with Cy3 or Cy5
fluorophores (Amersham) according to the manufac-
turer's instructions, analysed by 1.5% agarose gel electro-
phoresis, and visualized using a Typhoon fluorescence
scanner (Amersham) (see Additional file 5). These data
demonstrated that the majority of transcripts in each sam-
ple were approximately 150 nt – 400 nt in length, and the
lack of low molecular weight fluorescent signal confirmed
that all unincorporated dyes were successfully removed
during the purification procedure.
Microarray hybridizations
Interrogation of the 11.5 dpc, 12.5 dpc, and 13.5 dpc
cRNA samples by microarray analysis involved a saturated
hybridization strategy with dye swaps. Thus, cRNA sam-
ples from each time point were labelled with both Cy3
and Cy5 fluorophores, and six hybridizations were per-
formed such that each time point was compared with each
other time point using both dye combinations (to nor-
malize against dye biases). 44 K whole mouse genome
microarrays (G4122F, ID014868, Agilent) were hybrid-
ized according to the manufacturer's instructions. The
arrays were then scanned at 10 μm resolution on an Axon
4000B scanner and the features acquired with the GenePix
Pro 4.1 software (Axon Instruments). The raw data was
then processed using a print-tip loess normalization [68]BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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using limmaGUI [69,70] which is an implemented pack-
age of R used to fit linear models to microarray data http:/
/bioinf.wehi.edu.au/limma/. Genes were ranked accord-
ing to their differential expression and gene lists were gen-
erated based on biological process and function (GOStat
and OntoExpress).
PCR analysis
Semi-quantitative PCR was used for initial validation of
the differential expression of specific genes during hind
limb chondrogenesis. Reverse transcription reactions were
performed using equal quantities of cRNA as template, to
generate cDNA. Equal quantities of cDNA were used as
template for PCR amplification of specific genes, using
primers designed as close as possible to the end of the 3'
untranslated region of the cDNA sequence. To ensure that
the reactions were stopped during the linear phase of
amplification, reactions were set up in triplicate and rou-
tinely removed from the thermocycler at 25 cycles, 30
cycles, and 35 cycles. Quantitative PCR (qPCR) was used
for quantitative validation of the differential expression of
specific genes during hind limb chondrogenesis. Primers
for qPCR were designed using online software https://
www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp.
qPCR was performed using the FastStart TaqMan Probe
Master real time PCR kit in 10 μl reactions comprised of 5
μl Roche FastStart Probe Master (Rox), 50 ng cDNA, 240
nM additional ROX Reference Dye, 100 nM UPL Probe,
and 200 nM each primer. Thermal cycling was conducted
on an Applied Biosystems 7700 Real-Time PCR System, as
follows: initial denaturation at 95°C for 10 minutes, fol-
lowed by 50 cycles of denaturation at 95°C for 30 sec-
onds, annealing and polymerization at 60°C for one
minute. qPCR data were analyzed using Applied Biosys-
tems SDS 2.2.2 software. All primer sequences are availa-
ble on request.
Histology
Toluidine Blue staining with Fast Green counter-staining
[71] was used to detect accumulation of proteoglycans in
sagittal cryosections of embryonic mouse limb buds, as a
histological assay for chondrogenesis.
In situ hybridization
Hindlimbs from E11.5, 12.5 and 13.5 embryos were fixed
overnight in 4% PFA then cyroprotected by immersion in
30% sucrose overnight. 12 μm frozen sections were then
subjected to in situ hybridization for each gene [72].
Abbreviations
aRNA: amplified RNA; cRNA: complementary RNA; dpc:
days post coitum; GO: gene ontology; qPCR: quantitative
PCR; RT-PCR: reverse transcription PCR.
Mouse hindlimb microdissections Figure 6
Mouse hindlimb microdissections. 11.5 dpc, 12.5 dpc, and 13.5 dpc mouse hindlimb cryosections stained with Toluidine 
Blue. Upper panels (A-C) show intact tissue; lower panels (D-F) show cryosections following microdissection of tibial and 
fibular tissues. Staining of tissues shown in lower panels was performed following microdissection. T = Tibia, F = Fibula. Scale 
bar = 500 μm.BMC Developmental Biology 2009, 9:20 http://www.biomedcentral.com/1471-213X/9/20
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